New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding Jan. 31, 2022 No Comments
Dual Kv7 channel/TPSO receptor activator GRT-X shows promise in a refractory seizure model Jan. 31, 2022 No Comments
Discovery of VU-6015241, a novel M4 antagonist with promising preclinical profile Jan. 26, 2022 No Comments
IM-1761065, a novel biguanide with promising activity in models of glioblastoma Jan. 24, 2022 No Comments
Macolacin, a novel naturally inspired antibiotic with efficacy against MDR pathogens Jan. 21, 2022 No Comments
Researchers publish data on DDR kinase inhibitor XBLJ-13 for pulmonary fibrosis Jan. 10, 2022 No Comments
MCUF-651, a GC-A PAM for the treatment of cardiovascular, renal and metabolic diseases Jan. 5, 2022 No Comments
Discovery of novel ABCB1 inhibitors that can help overcome ABCB1-mediated chemotherapy resistance Dec. 29, 2021 No Comments
RSS